| Abramson Hospice 1425 Horsham Road, North Wales, PA, 19454 | |
| (215) 371-3000 |
News Archive
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company intends to issue the one-time special dividend to all existing shareholders pursuant to the perpetual license sale of technology rights to SAFECODE DRUG TECHNOLOGIES CORP.
Research by industrial engineering and biology researchers at Kansas State University marks a significant milestone in the battle against sepsis, the second highest cause of death in intensive care units in the U.S.
Dezima Pharma ('Dezima'), the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the in-licensing of a cholesteryl ester transfer protein (CETP) inhibitor DEZ-001 (formerly TA-8995) from Mitsubishi Tanabe Pharma Corporation (MTPC). Terms of the deal were not disclosed.
Stem cell-enriched fat grafting could become central to plastic and reconstructive surgery after the first randomised trial in humans confirms the technique's excellent feasibility and safety.
Congressman Chaka Fattah (D-PA), Chairman of the Congressional Urban Caucus and Pennsylvania's senior appropriator on the House Appropriations Committee, issues the following statement on hypocritical disparity in the national priorities regarding property insurance versus health insurance.
› Verified 2 days ago
| Name | Abramson Hospice |
|---|---|
| Location | 1425 Horsham Road, North Wales, Pennsylvania |
| Hospice ID | 391700 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Other |
| Profit Type | NON-PROFIT |
| SSA county code | 560 |
News Archive
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company intends to issue the one-time special dividend to all existing shareholders pursuant to the perpetual license sale of technology rights to SAFECODE DRUG TECHNOLOGIES CORP.
Research by industrial engineering and biology researchers at Kansas State University marks a significant milestone in the battle against sepsis, the second highest cause of death in intensive care units in the U.S.
Dezima Pharma ('Dezima'), the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the in-licensing of a cholesteryl ester transfer protein (CETP) inhibitor DEZ-001 (formerly TA-8995) from Mitsubishi Tanabe Pharma Corporation (MTPC). Terms of the deal were not disclosed.
Stem cell-enriched fat grafting could become central to plastic and reconstructive surgery after the first randomised trial in humans confirms the technique's excellent feasibility and safety.
Congressman Chaka Fattah (D-PA), Chairman of the Congressional Urban Caucus and Pennsylvania's senior appropriator on the House Appropriations Committee, issues the following statement on hypocritical disparity in the national priorities regarding property insurance versus health insurance.
› Verified 2 days ago
| NPI Number | 1598752206 |
| Organization Name | Madlyn And Leonard Abramson Center For Jewish Life |
| Address | 1425 Horsham Rd North Wales, Pennsylvania, 19454 |
| Phone Number | (215)371-3000 |
News Archive
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company intends to issue the one-time special dividend to all existing shareholders pursuant to the perpetual license sale of technology rights to SAFECODE DRUG TECHNOLOGIES CORP.
Research by industrial engineering and biology researchers at Kansas State University marks a significant milestone in the battle against sepsis, the second highest cause of death in intensive care units in the U.S.
Dezima Pharma ('Dezima'), the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the in-licensing of a cholesteryl ester transfer protein (CETP) inhibitor DEZ-001 (formerly TA-8995) from Mitsubishi Tanabe Pharma Corporation (MTPC). Terms of the deal were not disclosed.
Stem cell-enriched fat grafting could become central to plastic and reconstructive surgery after the first randomised trial in humans confirms the technique's excellent feasibility and safety.
Congressman Chaka Fattah (D-PA), Chairman of the Congressional Urban Caucus and Pennsylvania's senior appropriator on the House Appropriations Committee, issues the following statement on hypocritical disparity in the national priorities regarding property insurance versus health insurance.
› Verified 2 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.6 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 98.8 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 42.1 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company intends to issue the one-time special dividend to all existing shareholders pursuant to the perpetual license sale of technology rights to SAFECODE DRUG TECHNOLOGIES CORP.
Research by industrial engineering and biology researchers at Kansas State University marks a significant milestone in the battle against sepsis, the second highest cause of death in intensive care units in the U.S.
Dezima Pharma ('Dezima'), the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the in-licensing of a cholesteryl ester transfer protein (CETP) inhibitor DEZ-001 (formerly TA-8995) from Mitsubishi Tanabe Pharma Corporation (MTPC). Terms of the deal were not disclosed.
Stem cell-enriched fat grafting could become central to plastic and reconstructive surgery after the first randomised trial in humans confirms the technique's excellent feasibility and safety.
Congressman Chaka Fattah (D-PA), Chairman of the Congressional Urban Caucus and Pennsylvania's senior appropriator on the House Appropriations Committee, issues the following statement on hypocritical disparity in the national priorities regarding property insurance versus health insurance.
› Verified 2 days ago
| Home Health Aides | 13.5 |
| Counselors | 2 |
| Medical Social Workers | 1.5 |
| Physicians | 0.25 |
| Registered Nurses | 2 |
| Other Personnel | 2 |
| Total Employees | 21.25 |
|---|
News Archive
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company intends to issue the one-time special dividend to all existing shareholders pursuant to the perpetual license sale of technology rights to SAFECODE DRUG TECHNOLOGIES CORP.
Research by industrial engineering and biology researchers at Kansas State University marks a significant milestone in the battle against sepsis, the second highest cause of death in intensive care units in the U.S.
Dezima Pharma ('Dezima'), the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the in-licensing of a cholesteryl ester transfer protein (CETP) inhibitor DEZ-001 (formerly TA-8995) from Mitsubishi Tanabe Pharma Corporation (MTPC). Terms of the deal were not disclosed.
Stem cell-enriched fat grafting could become central to plastic and reconstructive surgery after the first randomised trial in humans confirms the technique's excellent feasibility and safety.
Congressman Chaka Fattah (D-PA), Chairman of the Congressional Urban Caucus and Pennsylvania's senior appropriator on the House Appropriations Committee, issues the following statement on hypocritical disparity in the national priorities regarding property insurance versus health insurance.
› Verified 2 days ago
| Others | 0.6 |
| Total Volunteers | 0.6 |
|---|
News Archive
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company intends to issue the one-time special dividend to all existing shareholders pursuant to the perpetual license sale of technology rights to SAFECODE DRUG TECHNOLOGIES CORP.
Research by industrial engineering and biology researchers at Kansas State University marks a significant milestone in the battle against sepsis, the second highest cause of death in intensive care units in the U.S.
Dezima Pharma ('Dezima'), the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the in-licensing of a cholesteryl ester transfer protein (CETP) inhibitor DEZ-001 (formerly TA-8995) from Mitsubishi Tanabe Pharma Corporation (MTPC). Terms of the deal were not disclosed.
Stem cell-enriched fat grafting could become central to plastic and reconstructive surgery after the first randomised trial in humans confirms the technique's excellent feasibility and safety.
Congressman Chaka Fattah (D-PA), Chairman of the Congressional Urban Caucus and Pennsylvania's senior appropriator on the House Appropriations Committee, issues the following statement on hypocritical disparity in the national priorities regarding property insurance versus health insurance.
› Verified 2 days ago
| Abramson Hospice Location: 1425 Horsham Road, North Wales, Pennsylvania, 19454 Phone: (215) 371-3000 |